Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05114005 · ClinicalTrials.gov registry record · NA
Tango for Neuropathy Among Breast Cancer Survivors
A NA study of Neuropathy and Cancer, Breast, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT05114005: Completed NA study of Neuropathy and Cancer, Breast, sponsored by Ohio State University Comprehensive Cancer Center.
NCT05114005 is a NA study of Neuropathy and Cancer, Breast that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 52 participants, below the 184-participant average among 22 other Neuropathy trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05114005, a NA study of Neuropathy and Cancer, Breast, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
Group dance classes have been found to improve markers of quality of life and physical health (i.e., balance) among some populations engaged in rehabilitation, such as the elderly and individuals with Parkinson Disease. However, such interventions have yet to be studied among cancer survivors despite the relevance of quality of life and physical health within cancer survivorship. Group dance classes are a promising avenue in that they deliver activity-based medicine in a social context, thus potentially improving physical as well as psychosocial aspects of health. To further this avenue of inquiry, we propose to study the effect of dance-based interventions for cancer survivors.
Primary Outcome
root-mean square of the center of pressure (COP)
Conditions Studied
Interventions
- BEHAVIORAL Rhythmic Auditory Stimulation
- BEHAVIORAL Evidence-Based Exercise
Study Locations (1)
Ohio
- Stephanie Spielman Comprehensive Breast Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2021-08-15 |
| Est. Completion | 2024-04-15 |
| Phase | NA |
What the finished NCT05114005 record still lists
NCT05114005 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 184-participant average among 22 other Neuropathy trials with a reported enrollment target (72% lower).
The record links to 2 conditions, with Neuropathy appearing as the primary indexed condition, and to 2 interventions - of which Rhythmic Auditory Stimulation is the first listed.
NCT05114005 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05114005 about?
NCT05114005 is a clinical study titled "Tango for Neuropathy Among Breast Cancer Survivors". Group dance classes have been found to improve markers of quality of life and physical health (i.e., balance) among some populations engaged in rehabilitation, such as the elderly and individuals with Parkinson Disease. However, such interventions have yet to be studied among cancer survivors despit...
What is the current status of trial NCT05114005?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2021-08-15. Estimated completion is 2024-04-15.
What conditions does trial NCT05114005 study?
This clinical trial studies the following conditions: Neuropathy, Cancer, Breast.
What interventions are being tested in trial NCT05114005?
The interventions under investigation include: Rhythmic Auditory Stimulation (BEHAVIORAL), Evidence-Based Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT05114005?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05114005 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05114005's enrollment target sits among peer trials
52 15th of 22 higher than 8 of 22 other Neuropathy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neuropathy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)
RECRUITING · NA
-
Daily Hand-Held Vibration Therapy
RECRUITING · NA
-
Clinical Efficacy of the Erchonia EVRL for Providing Temporary Relief of Idiopathic Peripheral Neuropathy Foot Pain
RECRUITING · NA
-
Improving Autonomic Function and Balance in Diabetic Neuropathy
ACTIVE NOT RECRUITING · NA
-
rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin Chemotherapy
ACTIVE NOT RECRUITING · NA
-
The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI